Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 1896285, 7 pages
http://dx.doi.org/10.1155/2016/1896285
Clinical Study

Growth Hormone Therapy Benefits Pituitary Stalk Interruption Syndrome Patients with Short Stature: A Retrospective Study of 75 Han Chinese

1Department of Endocrinology, Chinese PLA General Hospital, Beijing 100853, China
2Department of Endocrinology, Beijing Electric Teaching Hospital of Capital Medical University, Beijing 100073, China
3Department of Endocrinology, Hainan Branch of Chinese PLA General Hospital, Sanya, Hainan 572000, China

Received 8 February 2016; Revised 28 March 2016; Accepted 30 March 2016

Academic Editor: Maria L. Dufau

Copyright © 2016 Cheng-Zhi Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Yang, Q.-H. Guo, and Y.-M. Mu, “Advance in diagnosis and therapy of pituitary stalk interruption syndrome,” Chinese Journal of Clinical Endocrinology and Metabolism, vol. 27, no. 11, pp. 952–956, 2011. View at Google Scholar
  2. E. Karaca, R. Buyukkaya, D. Pehlivan et al., “Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome,” The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 1, pp. E140–E147, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. El Chehadeh-Djebbar, P. Callier, A. Masurel-Paulet et al., “17q21.31 microdeletion in a patient with pituitary stalk interruption syndrome,” European Journal of Medical Genetics, vol. 54, no. 3, pp. 369–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Reynaud, S. A. Jayakody, C. Monnier et al., “PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 6, pp. E1068–E1073, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Bar, C. Zadro, G. Diene et al., “Pituitary stalk interruption syndrome from infancy to adulthood: clinical, hormonal, and radiological assessment according to the initial presentation,” PLOS ONE, vol. 10, no. 11, Article ID e0142354, 2015. View at Publisher · View at Google Scholar
  6. R. Reynaud, F. Albarel, A. Saveanu et al., “Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms,” European Journal of Endocrinology, vol. 164, no. 4, pp. 457–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Melo, S. Marui, L. R. Carvalho et al., “Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe,” Clinical Endocrinology, vol. 66, no. 1, pp. 95–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Fernandez-Rodriguez, C. Quinteiro, J. Barreiro et al., “Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis,” Neuroendocrinology, vol. 93, no. 3, pp. 181–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Tauber, J. Chevrel, G. Diene et al., “Long-term evolution of endocrine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome,” Hormone Research, vol. 64, no. 6, pp. 266–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. El Chehadeh, C. Bensignor, J.-V. de Monléon, N. Méjean, and F. Huet, “The pituitary stalk interruption syndrome: endocrine features and benefits of growth hormone therapy,” Annales d'Endocrinologie, vol. 71, no. 2, pp. 102–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Coutant, S. Rouleau, F. Despert, N. Magontier, D. Loisel, and J.-M. Limal, “Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4649–4654, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Boersma, B. Rikken, and J. M. Wit, “Catch-up growth in early treated patients with growth hormone deficiency. Dutch Growth Hormone Working Group,” Archives of Disease in Childhood, vol. 72, no. 5, pp. 427–431, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Huet, J.-C. Carel, J.-L. Nivelon, and J.-L. Chaussain, “Long-term results of GH therapy in GH-deficient children treated before 1 year of age,” European Journal of Endocrinology, vol. 140, no. 1, pp. 29–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. Q.-H. Guo, Y. Yang, Y.-M. Mu et al., “Pituitary stalk interruption syndrome in chinese people: clinical characteristic analysis of 55 cases,” PLoS ONE, vol. 8, no. 1, Article ID e53579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Yang, Q.-H. Guo, B.-A. Wang et al., “Pituitary stalk interruption syndrome in 58 Chinese patients: clinical features and genetic analysis,” Clinical Endocrinology, vol. 79, no. 1, pp. 86–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Louvel, M. Marcu, C. Trivin, J.-C. Souberbielle, and R. Brauner, “Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency,” BMC Pediatrics, vol. 9, article 29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-L. Pham, P. Lemaire, A. Harroche, J.-C. Souberbielle, and R. Brauner, “Pituitary stalk interruption syndrome in 53 postpubertal patients: factors influencing the heterogeneity of its presentation,” PLoS ONE, vol. 8, no. 1, Article ID e53189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. L. Tsai, E. Laffan, and S. Lawrence, “A retrospective review of pituitary MRI findings in children on growth hormone therapy,” Pediatric Radiology, vol. 42, no. 7, pp. 799–804, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Antoniazzi, P. Cavarzere, and R. Gaudino, “Growth hormone and early treatment,” Minerva endocrinologica, vol. 40, no. 2, pp. 129–143, 2015. View at Google Scholar · View at Scopus
  20. P. J. Simm, A. Bajpai, V. C. Russo, and G. A. Werther, “Estrogens and growth,” Pediatric Endocrinology Reviews, vol. 6, no. 1, pp. 32–41, 2008. View at Google Scholar · View at Scopus
  21. K. S. Shim, “Pubertal growth and epiphyseal fusion,” Annals of Pediatric Endocrinology & Metabolism, vol. 20, no. 1, pp. 8–12, 2015. View at Publisher · View at Google Scholar
  22. M. Weise, S. De-Levi, K. M. Barnes, R. I. Gafni, V. Abad, and J. Baron, “Effects of estrogen on growth plate senescence and epiphyseal fusion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 12, pp. 6871–6876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Melmed, “Supplemental growth hormone in healthy adults: the endocrinologist's responsibility,” Nature Clinical Practice Endocrinology and Metabolism, vol. 2, no. 3, p. 119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Hartman, R. Xu, B. J. Crowe et al., “Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients,” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 3, pp. 980–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Tauber, P. Moulin, C. Pienkowski, B. Jouret, and P. Rochiccioli, “Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 2, pp. 352–356, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Maghnie, C. Strigazzi, C. Tinelli et al., “Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 4, pp. 1324–1328, 1999. View at Publisher · View at Google Scholar · View at Scopus